LAMEA (Brazil, Saudi Arabia, South Africa, Rest of LAMEA) By Key Market Players Cadwell Industries, Inc. Compumedics Limited Drive DeVilbiss Healthcare Inc. GlaxoSmithKline Plc Merck& Co., Inc. Natus Medical Inc. Koninklijke Philips N.V. PFIZER, INC. Sanofi S.A. SleepMed ...
The report covers Topical Drugs Market Companies & Growth and the market is segmented by Route of Administration (Dermal, Ophthalmic, Nasal, Oral, and Others), Product (Formulation and Device), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The ...
The increasing price of regular supplements and the high price of premiumized supplements are expected to restrain the dietary supplements market growth. The rising consumer inclination toward organic products and the limited availability of organic supplements can further hamper the market’s growth. How...
Pfizer held nine percent of the world's pharmaceutical drug market in 2022. The global market for prescribed medicines is expected to be led by U.S. companies, accompanied by Swiss pharma giants Roche and Novartis. Prescription and over-the-counter drugsThe total global prescription drug market ...
Key players such as Pfizer, Eli Lilly, and Johnson & Johnson dominate with a diverse portfolio of analgesic drugs and medical devices targeting specific pain types. Emerging entrants like Teva Pharmaceuticals and Endo International are gaining traction through novel formulations and expanded market reach...
6.1.7 Pfizer Inc. 6.1.8 Takeda Pharmaceutical Company Limited 6.1.9 Bausch Health Companies Inc. (Salix Pharmaceuticals Inc.) 6.1.10 Boehringer Ingelheim International GmbH 6.1.11 Cipla Inc. 6.1.12 Sebela Pharmaceuticals *List Not Exhaustive ...
Brand name medications are particularly expensive in the country: the average price of Humira in the United States is far higher than in other markets. Branded drugs enjoy the protection of patents, and the lack of competition means both manufacturers and pharmacies can charge what the market ...
1.15% at 10:11 GMT to trade at €25.41 in Frankfurt. The company is valued at 6.29 billion. According to the Financial Times, the 8 analysts offering 12-month price targets for Zalando SE have a median target of €24.70, with a high estimate of €27.50 and a low estimate of €13....
Key Companies ProfiledKirin Holdings Company Limited; Vericel Corporation; Mereo Biopharma Group plc; Novartis AG; AM-Pharma B.V.; Bayer AG; Pfizer Inc.; Ultragenyx Pharmaceutical Inc.; BioMarin Pharmaceutical Inc.; Prior Company Ltd.; Enobia Pharma Corporation; AstraZeneca plc; Rallybio Corporati...
The report extensively examines the global Scleroderma Therapeutics market while focusing on the leading companies and their business strategies, geographical growth, market segmentation, competitive environment, production, price, and cost structures. Each section of the research report has been carefully ...